Publication | Open Access

Two Novel Tau Antibodies Targeting the 396/404 Region Are Primarily Taken Up by Neurons and Reduce Tau Protein Pathology

Neurodegenerative DiseasesNovel Tau AntibodiesAutoimmune DiseaseMedicineImmunologyDegenerative DiseaseDegenerative PathologyNeurochemical BiomarkersProtein MisfoldingNeuroimmunologyCell Biology